Literature DB >> 11130015

Radiation therapy approach in gliomatosis cerebri--case reports and literature review.

E Horst1, O Micke, M L Romppainen, J Pyhtinen, W Paulus, U Schäfer, C Rübe, N Willich.   

Abstract

Gliomatosis cerebri is defined as a remarkably diffuse glioma, characterized by widespread infiltration of the central nervous system. Clinicopathologic characteristics and imaging findings have been published but valid classification remains controversial. Few reports exist regarding therapeutic options in gliomatosis cerebri. Here we review data on 17 patients treated with radiation therapy extracted from the literature, in which we focus our attention on available details of irradiation and clinical outcome and present the results of three additional patients treated at our two institutions. Radiologic-pathologic correlation in gliomatosis cerebri indicates that tumor delineation should be based on T2-weighted MRI. Radiation therapy in gliomatosis cerebri is associated with a temporary improvement in or stabilization of clinical symptoms in the majority of cases. Duration of improvement was > or = 6 months in 50% of treated patients. Survival from onset of symptoms was 23.8 months (range 8-42). Considerable variation in the natural course of the disease precludes conclusions regarding the impact of radiation therapy on survival.

Entities:  

Mesh:

Year:  2000        PMID: 11130015     DOI: 10.1080/028418600750063839

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  8 in total

1.  Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature.

Authors:  Sophie Taillibert; Catherine Chodkiewicz; Florence Laigle-Donadey; Massimo Napolitano; Stéphanie Cartalat-Carel; Marc Sanson
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

2.  Wide Range of Clinical Outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A Clinical, Radiographic, and Histopathologic Study.

Authors:  K Ina Ly; Derek H Oakley; Alexander B Pine; Matthew P Frosch; Sy Han Chiou; Rebecca A Betensky; Stuart R Pomerantz; Fred H Hochberg; Tracy T Batchelor; Daniel P Cahill; Jorg Dietrich
Journal:  Oncologist       Date:  2018-08-10

3.  Gliomatosis cerebri in children. Case report and clinical considerations.

Authors:  Emanuela Caroli; Epimenio Ramundo Orlando; Luigi Ferrante
Journal:  Childs Nerv Syst       Date:  2005-01-27       Impact factor: 1.475

4.  Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases.

Authors:  Tomoo Inoue; Toshihiro Kumabe; Masayuki Kanamori; Yukihiko Sonoda; Mika Watanabe; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2011-02-08       Impact factor: 3.042

5.  Presentation patterns and outcome of gliomatosis cerebri.

Authors:  Gustavo G Rajz; Dvora Nass; Elisa Talianski; Raphael Pfeffer; Roberto Spiegelmann; Zvi R Cohen
Journal:  Oncol Lett       Date:  2011-10-18       Impact factor: 2.967

6.  Gliomatosis cerebri: clinical characteristics, management, and outcomes.

Authors:  Selby Chen; Shota Tanaka; Caterina Giannini; Jonathan Morris; Elizabeth S Yan; Jan Buckner; Daniel H Lachance; Ian F Parney
Journal:  J Neurooncol       Date:  2013-01-23       Impact factor: 4.130

7.  Gliomatosis cerebri mimicking encephalitis evaluated using fluorine-18 fluorodeoxyglucose: Positron emission tomography/computed tomography.

Authors:  Koramadai Karuppusamy Kamaleshwaran; Vijayan Krishnan; Vyshakh Mohanan; Deepu Shibu; Ajit Sugunan Shinto
Journal:  Indian J Nucl Med       Date:  2015 Jan-Mar

8.  Pediatric gliomatosis cerebri mimicking tubercular encephalitis.

Authors:  Namit Singhal; Vinay Agarwal
Journal:  J Pediatr Neurosci       Date:  2015 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.